Nitric oxide, cell death, and heart failure

Heart Failure Reviews

Volumn 7, Issue 4, 2002, Pages 327-334

  Oyama, Jun Ichi ^a   Frantz, Stefan ^c   Blais Jr , Charles ^a   Kelly, Ralph A ^b   Bourcier, Todd ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b GENZYME CORPORATION   (United States)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Apoptosis; Heart failure; Necrosis; Nitric oxide

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; ARGININE DERIVATIVE; BETA ADRENERGIC RECEPTOR; CASPASE; CASPASE 3; CASPASE 8; CERAMIDE; CYCLIC GMP; CYTOCHROME C; DNA; GAMMA INTERFERON; GLYCOPROTEIN GP 130; GUANYLATE CYCLASE; INTERLEUKIN 1BETA; INTERLEUKIN 6 RECEPTOR; ISOENZYME; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN BCL XL; PROTEIN P53; RIBONUCLEOTIDE REDUCTASE; SCAVENGER; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

APOPTOSIS; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CYTOTOXICITY; DEGENERATIVE DISEASE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DRUG ACTIVITY; DRUG PROTEIN BINDING; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PACING; HEART STRESS; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MUSCLE CELL; MYOCARDITIS; NECROSIS; NONHUMAN; PATHOGENESIS; PLEIOTROPY; REPERFUSION INJURY; REVIEW; TUMOR SUPPRESSOR GENE; CONGESTIVE HEART FAILURE; GENETICS; HEART LEFT VENTRICLE FUNCTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

APOPTOSIS; GENES, TUMOR SUPPRESSOR; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036813715     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020758300499     Document Type: Review

References (89)

1. Colucci WS, Braunwald E. Pathophysiology of Heart Failure, 6th ed. Philadelphia: W.B. Saunders Company, 2001. (Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A textbook of Cardiovascular Medicine).
2. Anversa P, Olivetti G,Capasso JM. Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol 1991;68(14):7D-16.
3. Curtiss C, Cohn JN, Vrobel T, Franciosa JA. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 1978;58(5):763-770.
4. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982;49(7):1659-1666.
5. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319(2):80-86.
6. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodeling. Nature 2002;415(6868):240-243.
7. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344(23):1750-1757.
8. Kang PM, Izumo S. Apoptosis and heart failure: A critical review of the literature. Circ Res 200;86(11):1107-1113.
9. Sabbah HN. Apoptotic cell death in heart failure. Cardiovasc Res 2000;45(3):704-712.
10. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336(16):1131-1141.
11. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 1997;272 (5 Pt 2):H2313-H2319.
12. Leri A, Liu Y, Malhotra A, et al. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 1998;97(2):194-203.
13. Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28(9):2005-2016.
14. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997;95(2):320-323.
15. Toyozaki T, Hiroe M, Tanaka M, Nagata S, Ohwada H, Marumo F. Levels of soluble Fas ligand in myocarditis. Am J Cardiol 1998;82(2):246-248.
16. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335(16):1182-1189.
17. Anversa P, Kajstura J. Myocyte cell death in the diseased heart. Circ Res 1998;82(11):1231-1233.
18. Eastman A, Barry MA. The origins of DNA breaks: A consequence of DNA damage, DNA repair, or apoptosis? Cancer Invest 1992;10(3):229-240.
19. Gold R, Schmied M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71(2):219-225.
20. Kanoh M, Takemura G, Misao J, et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation 1999;99(21):2757-2764.
21. Ohno M, Takemura G, Ohno A, et al. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immunogold electron microscopy combined with In situ nick end-labeling. Circulation 1998;98(14):1422-1430.
22. Sloop GD, Roa JC, Delgado AG, Balart JT, Hines MO, III, Hill JM. Histologic sectioning produces TUNEL reactivity. A potential cause of false-positive staining. Arch Pathol Lab Med 199;123(6):529-532
23. Haunstetter A, Izumo S. Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res 1998;82(11):1111-1129.
24. Haunstetter A, Izumo S. Future perspectives and potential implications of cardiac myocyte apoptosis. Cardiovasc Res 2000;45(3):795-801.
25. Haunstetter A, Izumo S. Toward antiapoptosis as a new treatment modality. Circ Res 2000;86(4):371-376.
26. Hirota H, Chen J, Betz UA, et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999;97(2):189-198.
27. Pannitteri G, Marino B, Campa PP, Martucci R, Testa U, Peschle C. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol 1997;80(5):622-625.
28. Wencker D, Nguyen K, Khine C, et al. Myocyte apoptosis in sufficient to cause dilated cardiomyopathy. Circulation 1999;100(Supp I):1-17.
29. Geng YJ, Ishikawa Y, Vatner DE, et al. Apoptosis of cardiac myocytes in Gsalpha transgenic mice. Circ Res 1999;84(1):34-42.
30. Hibbs JB Jr. Taintor RR, Vavrin Z. Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987;235(4787):473-476.
31. Hibbs JB Jr, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987;138(2):550-565.
32. Brown GC, Borutaite V. Nitric oxide, cytochrome c and mitochondria. Biochem Soc Symp 1999;66:17-25.
33. Brown GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999;1411(2,3):351-369.
34. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83(5):1774-1777.
35. Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 1994;269(47):29405-29408.
36. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993;150(11):5080-5085.
37. Balligand JL, Cannon PJ. Nitric oxide synthases and cardiac muscles. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol 1997;17(10):1846-1858.
38. De Belder AJ, Radomski MW, Why HJ, et al. Nitric oxide synthase activities in human myocardium. Lancet 1993;341(8837):84-85.
39. De Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J 1995;74(4):426-430.
40. Haywood GA, Tsao PS, Von Der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93(6):1087-1094.
41. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest 1995;95(2):677-685.
42. Szabolcs M, Michler RE, Yang X, et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation 1996;94(7):1665-1673.
43. Lepoivre M, Flaman JM, Bobe P, Lemaire G, Henry Y. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J Biol Chem 1994;269(34):21891-21897.
44. Szabeo C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscles cells exposed toperoxynitrite. Proc Natl Acad Sci USA 1996;93(5):1753-1758.
45. Messmer UK, Ankarcrona M, Nicotera P, Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355(1):23-26.
46. Ghafourifar P, Bringold U, Klein SD, Richter C. Mitochondrial nitric oxide synthase, oxidative stress and apoptosis. Biol Signals Recept 2001;10(1-2):57-65.
47. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000;102(1):33-42.
48. von Harsdorf R, Li PF, Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999;99(22):2934-2941.
49. Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 1996;328(1):85-92.
50. Forrester K, Ambs S, Lupold SE, et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 1996;93(6):2442-2447.
51. Pinsky DJ, Aji W, Szabolcs M, et al. Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. Am J Physiol 1999;277(3 Pt 2):H1189-H1199.
52. Mortensen K, Skouv J, Hougaard DM, Larsson LI. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem 1999;274(53):37679-37684.
53. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270(5240):1326-1331.
54. Jun CD, Pae HO, Kwak HJ, et al. Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways. Cell Immunol 1999;194(1):36-46.
55. Taimor G, Rakow A, Piper HM. Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes. FASEB J 2001;15(13):2518-2520.
56. Andreka P, Zhang J, Dougherty C, Slepak TI, Webster KA, Bishopric NH. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ Res 2001;88(3):305-312.
57. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990;30:535-560.
58. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329(27):2002-2012.
59. Shimojo T, Hiroe M, Ishiyama S, Ito H, Nishikawa T, Marumo F. Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp Cell Res 1999;247(1):38-47.
60. Arstall MA, Sawyer DB, Fukazawa R, Kelly RA. Cytokine-mediated apoptosis in cardiac myocytes: The role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 1999;85(9):829-840.
61. Brookes PS, Salinas EP, Darley-Usmar K, et al. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 2000;275(27):20474-20479.
62. Tejedo J, Bernabe JC, Ramirez R, Sobrino F, Bedoya FJ. NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. FEBS Lett 1999;459(2):238-243.
63. Huwiler A, Pfeilschifter J, van den Bosch H. Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells. J Biol Chem 1999;274(11):7190-7195.
64. Takeda Y, Tashima M, Takahashi A, Uchiyama T, Okazaki T. Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3. J Biol Chem 1999;274(15):10654-10660.
65. Di Nardo A, Benassi L, Magnoni C, Cossarizza A, Seidenari S, Giannetti A. Ceramide 2 (N-acetyl sphingosine) is associated with reduction in Bcl-2 protein levels by Western blotting and with apoptosis in cultured human keratinocytes. Br J Dermatol 2000;143(3):491-497.
66. Li J, Bombeck CA, Yang S, Kim YM, Billiar TR. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 1999;274(24):17325-17333.
67. Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96(5):2247-2259.
68. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999;84(3):253-256.
69. Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 1997;240(2):419-424.
70. Rossig L, Fichtscherer B, Breitschopf K, et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999;274(11):6823-6826.
71. Dimmeler S, Haendeler J, Sause A, Zeiher AM. Nitric oxide inhibits APO-1/Fas-mediated cell death. Cell Growth Differ 1998;9(5):415-422.
72. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 1995;95(4):1884-1890.
73. Kim YM, De Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997;272(2):1402-1411.
74. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 1993;90(21):9813-9817.
75. Rabkin SW, Kong JY. Nitroprusside induces cardiomyocyte death: Interaction with hydrogen peroxide. Am J Physiol Heart Circ Physiol 2000;279(6):H3089-H3100.
76. Ing DJ, Zang J, Dzau VJ, Webster KA, Bishopric NH. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res 1999;84(1):21-33.
77. Song W, Lu X, Feng Q. Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc Res 2000;45(3):595-602.
78. Weiland U, Haendeler J, Ihling C, et al. Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc Res 2000;45(3):671-678.
79. Kawaguchi H, Shin WS, Wang Y, et al. In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death. Identification using Sendai virus-coated liposomes. Circulation 1997;95(10):2441-2447.
80. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs. Circulation 1993;88(5 Pt 1):2337-2350.
81. Czarnowska E, Kurzelewski M, Beresewicz A, Karczmarewicz E. The role of endogenous nitric oxide in inhibition of ischemia/reperfusion-induced cardiomyocyte apoptosis. Folia Histochem Cytobiol 2001;39(2):179-180.
82. Rakhit RD, Mojet MH, Marber MS, Duchen MR. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation 2001;103(21):2617-2623.
83. Koglin J, Glysing-Jensen T, Mudgett JS, Russell ME. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: Insights from NOS2-knockout mice. Am J Pathol 1998;153(5):1371-1376.
84. Koglin J, Granville DJ, Glysing-Jensen T, et al. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. Circulation 1999;99(6):836-842.
85. Szabolcs MJ, Na N, Athan E, et al. Acute cardiac allograft rejection in nitric oxide synthase-2(-/-) and nitric oxide synthase-2(+/+) mice: Effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis. Circulation 2001;103(20):2514-2520.
86. Scherrer-Crosbie M, Ullrich R, Bloch KD, et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 2001;104(11):1286-1291.
87. Feng Q, Lu X, Jones DL, Shen J, Arnold JM. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 2001;104(6):700-704.
88. Sam F, Sawyer DB, Xie Z, et al. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 2001;89(4):351-356.
89. Leist M, Single B, Naumann H, Fava E, Simon B, Kuhne S, Nicotera P. Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp Cell Res 1999;249:396-403.